• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-IL-17A

IL-17A Monoclonal Antibody for WB, IF-P, ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, souris

Applications

WB, IF-P, ELISA

Conjugaison

Non conjugué

CloneNo.

1B3D5

N° de cat : 66148-1-PBS

Synonymes

IL 17, IL17, IL-17, IL17A, 1B3D5



Informations sur le produit

66148-1-PBS cible IL-17A dans les applications de WB, IF-P, ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène IL-17A Protéine recombinante Ag3733
Nom complet interleukin 17A
Masse moléculaire calculée 155 aa, 18 kDa
Poids moléculaire observé 18 kDa
Numéro d’acquisition GenBankBC067505
Symbole du gène IL-17A
Identification du gène (NCBI) 3605
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

IL17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased.

{{ptg:RelatedPrimaryAntibodies}}